These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4943273)

  • 1. Sensitive procedure for detecting residual viable virus in inactivated rabies vaccine.
    Mitchell JR; Everest RE; Anderson GR
    Appl Microbiol; 1971 Oct; 22(4):600-3. PubMed ID: 4943273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonal-centrifuged purified duck embryo cell culture rabies vaccine for human vaccination.
    Lavender JF; Van Frank RM
    Appl Microbiol; 1971 Sep; 22(3):358-65. PubMed ID: 5119204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of methods used for testing the safety of tissue culture rabies vaccines.
    Romanova LN; Polyushkina GS
    Dev Biol Stand; 1978; 40():209-13. PubMed ID: 680394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection.
    Moreira BLC; Gimenez APL; Inagaki JMF; Raboni SM
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008142. PubMed ID: 32210437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inactivated rabies vaccine, produced from a cell culture. Preliminary results].
    Branche R; Lang R; Petermann HG; Soulebot JP
    Prog Immunobiol Stand; 1967; 3():144-50. PubMed ID: 4908593
    [No Abstract]   [Full Text] [Related]  

  • 6. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
    van Wezel AL; van Steenis G; Hannik CA; Cohen H
    Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a real-time RT-PCR assay for the quantification of rabies virus as quality control of inactivated rabies vaccines.
    Lourenç Correia Moreira B; Aparecida Pereira L; Lappas Gimenez AP; Minor Fernandes Inagaki J; Raboni SM
    J Virol Methods; 2019 Aug; 270():46-51. PubMed ID: 31047970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.
    Wiktor TJ; Sokol F; Kuwert E; Koprowski H
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):799-805. PubMed ID: 5791793
    [No Abstract]   [Full Text] [Related]  

  • 9. A tissue-culture, modified live-virus rabies vaccine for dogs: report on development and clinical trial.
    Emery JB; Elliott AY; Bordt DE; Burch GR; Kugel EE
    J Am Vet Med Assoc; 1968 Mar; 152(5):476-82. PubMed ID: 5637640
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells.
    Chapman WG; Ramshaw IA; Crick J
    Appl Microbiol; 1973 Dec; 26(6):858-62. PubMed ID: 4588193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.
    Sikes RK; Cleary WF; Koprowski H; Wiktor TJ; Kaplan MM
    Bull World Health Organ; 1971; 45(1):1-11. PubMed ID: 5004004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethylenimine-inactivated rabies vaccine of tissue culture origin.
    Larghi OP; Savy VL; Nebel AE; Rodriguez A
    J Clin Microbiol; 1976 Jan; 3(1):26-33. PubMed ID: 1254701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonal-centrifuged human diploid cell rabies vaccine.
    Majer M; Hilfenhaus J; Mauler R; Hennessen W
    Dev Biol Stand; 1976 Dec 13-15; 37():267-71. PubMed ID: 801472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an assay for detecting the residual viable virus in inactivated rabies vaccine by enzyme-linked immunosorbent assay.
    Kawahara M; Takayama-Ito M; Kato H; Kitaura S; Satoh M; Saijo M
    Biologicals; 2021 Apr; 70():59-63. PubMed ID: 33518433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adaptation of a fixed rabies virus to monkey kidney cells. Use of this virus for the preparation of an inactivated anti-rabies vaccine].
    Lang R; Petermann HG; Branche R; Soulebot JP
    C R Acad Hebd Seances Acad Sci D; 1969 Dec; 269(22):2287-90. PubMed ID: 4983278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.
    FUENZALIDA E; PALACIOS R; BORGONO JM
    Bull World Health Organ; 1964; 30(3):431-6. PubMed ID: 14163964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.
    Biswas S; Reddy GS; Srinivasan VA; Rangarajan PN
    Hum Gene Ther; 2001 Oct; 12(15):1917-22. PubMed ID: 11589833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive in vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines.
    Takayama-Ito M; Nakamichi K; Kinoshita H; Kakiuchi S; Kurane I; Saijo M; Lim CK
    Biologicals; 2014 Jan; 42(1):42-7. PubMed ID: 24321529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.